These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24535036)

  • 1. Abnormal activation of the EGFR signaling pathway mediates the downregulation of miR‑145 through the ERK1/2 in non-small cell lung cancer.
    Guo YH; Zhang C; Shi J; Xu MH; Liu F; Yuan HH; Wang JY; Jiang B; Gao FH
    Oncol Rep; 2014 Apr; 31(4):1940-6. PubMed ID: 24535036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
    Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
    FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer.
    Li B; Ren S; Li X; Wang Y; Garfield D; Zhou S; Chen X; Su C; Chen M; Kuang P; Gao G; He Y; Fan L; Fei K; Zhou C; Schmit-Bindert G
    Lung Cancer; 2014 Feb; 83(2):146-53. PubMed ID: 24331411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EGFR-ERK signaling pathway down-regulates miRNA-145 in lung cancer cells].
    Guo YH; Gao FH; Shi J; Yuan HH; Jiang B
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):187-92. PubMed ID: 23879998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
    Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
    Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.
    Lee KM; Choi EJ; Kim IA
    Radiother Oncol; 2011 Oct; 101(1):171-6. PubMed ID: 21676478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of miRNAs that target EGFR mRNA in human lung cancer.
    Yamaguchi G; Takanashi M; Tanaka M; Fujita K; Ohira T; Kuroda M; Ikeda N
    Biochem Biophys Res Commun; 2012 Apr; 420(2):411-6. PubMed ID: 22426479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
    Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
    Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
    Cho WC; Chow AS; Au JS
    Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.
    Ke Y; Zhao W; Xiong J; Cao R
    FEBS Lett; 2013 Sep; 587(18):3153-7. PubMed ID: 23954293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
    Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
    Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.
    Song L; Morris M; Bagui T; Lee FY; Jove R; Haura EB
    Cancer Res; 2006 Jun; 66(11):5542-8. PubMed ID: 16740687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring microRNA-mediated alteration of EGFR signaling pathway in non-small cell lung cancer using an mRNA:miRNA regression model supported by target prediction databases.
    Wang F; Chan LW; Law HK; Cho WC; Tang P; Yu J; Shyu CR; Wong SC; Yip SP; Yung BY
    Genomics; 2014 Dec; 104(6 Pt B):504-11. PubMed ID: 25257143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of CDH1 up-regulates epidermal growth factor receptor via phosphorylation of YBX1 in non-small cell lung cancer cells.
    Liu X; Su L; Liu X
    FEBS Lett; 2013 Dec; 587(24):3995-4000. PubMed ID: 24211838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling.
    Kobayashi S; Shimamura T; Monti S; Steidl U; Hetherington CJ; Lowell AM; Golub T; Meyerson M; Tenen DG; Shapiro GI; Halmos B
    Cancer Res; 2006 Dec; 66(23):11389-98. PubMed ID: 17145885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
    Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
    Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.
    Zou M; Xia S; Zhuang L; Han N; Chu Q; Chao T; Peng P; Chen Y; Gui Q; Yu S
    Int J Oncol; 2013 Jun; 42(6):2094-102. PubMed ID: 23588221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.